The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Metal based drugs: from serendipity to design
Abstract
The platinum anticancer drug cisplatin has made a major contribution to the treatment of testicular and ovarian cancer. This chance discovery has been the stimulus for research into other metal-based drugs. Inorganic chemistry offers many opportunities for medicinal chemistry, and the discovery of metal-based drugs has moved on from chance discovery to rational drug design. There are however, many challenges associated with the drug discovery and development process. The aim of this review is to provide case histories exemplifying the role of rational drug design in modern inorganic medicinal chemistry in the context of these challenges. The evolution of platinum drugs from cisplatin to third generation drugs is described. The molecular target for the platinum agents is DNA. Alternative molecular targets such as thiol-containing proteins and redox processes are proposed. The example of a simple, safe, efficacious metal-based drug, Fosrenol, is reviewed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Nitric oxide: physiology, pathophysiology, and pharmacology.
Moncada, S., Palmer, R. M., & Higgs, E. A. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06663-3 · Cited by 15,525
Drug-like properties and the causes of poor solubility and poor permeability
Lipinski, C. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00107-6 · Cited by 3,734
Current Status of Platinum-Based Antitumor Drugs
Wong, E., & Giandomenico, C. M. (1999) · Chemical Reviews · doi:10.1021/cr980420v · Cited by 1,800
multifunctional enzymes in cancer
Mohamed, M. M., & Sloane, B. F. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1949 · Cited by 1,265
Shaw, C. F. (1999) · Chemical Reviews · doi:10.1021/cr980431o · Cited by 990
Hartinger, C. G., Zorbas-Seifried, S., Jakupec, M. A., Kynast, B., Zorbas, H., & Keppler, B. K. (2006) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2006.02.013 · Cited by 956
Aird, R. E., Cummings, J., Ritchie, A. A., Muir, M., Morris, R. E., Chen, H., Sadler, P. J., & Jodrell, D. I. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600290 · Cited by 582
Medicinal Inorganic Chemistry: Introduction
Orvig, C., & Abrams, M. J. (1999) · Chemical Reviews · doi:10.1021/cr980419w · Cited by 532
Vanadium in diabetes: 100 years from Phase 0 to Phase I
Thompson, K. H., & Orvig, C. (2006) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2006.08.016 · Cited by 508
The therapeutic application of lanthanides
Fricker, S. P. (2006) · Chemical Society Reviews · doi:10.1039/b509608c · Cited by 444
Self-citationNew approaches to molecular cancer therapeutics
Collins, I., & Workman, P. (2006) · Nature Chemical Biology · doi:10.1038/nchembio840 · Cited by 391
Guo, Z., & Sadler, P. J. (1999) · Advances in Inorganic Chemistry · doi:10.1016/s0898-8838(08)60271-8 · Cited by 354
Mort, J. S., & Buttle, D. J. (1997) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(96)00152-5 · Cited by 333
Ruthenium complexes can target determinants of tumour malignancy
Bergamo, A., & Sava, G. (2007) · Dalton Transactions · doi:10.1039/b617769g · Cited by 291
On the selectivity of superoxide dismutase mimetics and its importance in pharmacological studies
Muscoli, C., Cuzzocrea, S., Riley, D. P., Zweier, J. L., Thiemermann, C., Wang, Z., & Salvemini, D. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705430 · Cited by 271
Preclinical studies identifying carboplatin as a viable cisplatin alternative
Harrap, K. R. (1985) · Cancer Treatment Reviews · doi:10.1016/0305-7372(85)90015-5 · Cited by 259
Giandomenico, C. M., Abrams, M. J., Murrer, B. A., Vollano, J. F., Rheinheimer, M. I., Wyer, S. B., Bossard, G. E., & Higgins, J. D. (1995) · Inorganic Chemistry · doi:10.1021/ic00109a004 · Cited by 248
Making Better Drugs: Decision Gates in Non-Clinical Drug Development
Pritchard, J. F., Jurima-Romet, M., Reimer, M. L. J., Mortimer, E., Rolfe, B., & Cayen, M. N. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1131 · Cited by 246
Randomized Discontinuation Design: Application to Cytostatic Antineoplastic Agents
Rosner, G. L., Stadler, W., & Ratain, M. J. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.11.126 · Cited by 201
Inorganic Chemistry and Drug Design
Sadler, P. J. (1991) · Advances in Inorganic Chemistry · doi:10.1016/s0898-8838(08)60035-5 · Cited by 199
Holford, J., Sharp, S., Murrer, B., Abrams, M., & Kelland, L. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.59 · Cited by 196
Gold in medicine: A review of its use in the west before 1900
Higby, G. J. (1982) · Gold Bulletin · doi:10.1007/bf03214618 · Cited by 176
Bregman, H. S., Carroll, P. J., & Meggers, E. (2005) · Journal of the American Chemical Society · doi:10.1021/ja055523r · Cited by 165
Immediate (type I) allergic responses to platinum compounds
Cleare, M. J., Hughes, E. G., Jacoby, B., et al. (1976) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.1976.tb01897.x · Cited by 149
Fricker, S. P., Slade, E., Powell, N. A., et al. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701504 · Cited by 142
Self-citationRaynaud, F. I., Boxall, F. E., Goddard, P. M., Valenti, M. R., Jones, M. A., Murrer, B. A., Abrams, M., & Kèlland, L. R. (1997) · PubMed · Cited by 121
Lanthanum carbonate: a new phosphate binder
Behets, G. J. S., Verberckmoes, S. C., D’Haese, P. C., & Broe, M. E. D. (2004) · Current Opinion in Nephrology & Hypertension · doi:10.1097/01.mnh.0000133973.86816.e9 · Cited by 97
Grover, R., Lopez, A., Lorente, J. A., Steingrub, J. S., Bakker, J., Willatts, S. M., McLuckie, A., & Takala, J. A. (1999) · Critical Care Medicine · doi:10.1097/00003246-199901001-00021 · Cited by 83
Ruthenium(III) Polyaminocarboxylate Complexes: Efficient and Effective Nitric Oxide Scavengers
Cameron, B. R., Darkes, M. C., Yee, H., Olsen, M., Fricker, S. P., Skerlj, R. T., Bridger, G. J., Davies, N. A., Wilson, M. T., Rose, D. J., et al. (2003) · Inorganic Chemistry · doi:10.1021/ic020219+ · Cited by 56
Self-citationUse of nitric oxide synthase inhibitors to treat septic shock
Cobb, J. P. (1999) · Critical Care Medicine · doi:10.1097/00003246-199905000-00002 · Cited by 53
Malluche, H. H. (2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/17.7.1170 · Cited by 53
Design of Cathepsin K Inhibitors for Osteoporosis
Deaton, D. N., & Tavares, F. X. (2005) · Current Topics in Medicinal Chemistry · doi:10.2174/156802605775009676 · Cited by 35
Pieper, G. M., Roza, A. M., Adams, M. B., Hilton, G., Johnson, M. S., Felix, C. C., Kampalath, B., Darkes, M. C., Wanggui, Y., Cameron, B. R., et al. (2002) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200203000-00016 · Cited by 32
Self-citationMayers, I., Hurst, T. S., Radomski, A. S., Johnson, D. H., Fricker, S. P., Bridger, G. J., Cameron, B. R., Darkes, M. C., & Radomski, M. W. (2003) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1067/mtc.2003.38 · Cited by 25
Self-citation
Cited by
Metallodrugs in Medicinal Inorganic Chemistry
Mjos, K. D., & Orvig, C. (2014) · Chemical Reviews · doi:10.1021/cr400460s · Cited by 1,289
Application of Metal Coordination Chemistry To Explore and Manipulate Cell Biology
Haas, K. L., & Franz, K. J. (2009) · Chemical Reviews · doi:10.1021/cr900134a · Cited by 984
Targeting and delivery of platinum-based anticancer drugs
Wang, X., & Guo, Z. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35259a · Cited by 684
Recent developments in ruthenium anticancer drugs
Levina, A., Mitra, A., & Lay, P. A. (2009) · Metallomics · doi:10.1039/b904071d · Cited by 592
van Rijt, S. H., & Sadler, P. J. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.09.003 · Cited by 592
Metadata
- Authors
- Fricker, S. P.
- Venue
- Dalton Transactions
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2007
- Issue
- 43
- Pages
- 4903
- ISSN
- 1477-9226 (ISSN-L)
- 1477-9234
- OpenAlex
- W2104926349
- Cited by
- 414
- References
- 35
- FWCI
- 6.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.